119 related articles for article (PubMed ID: 7912735)
1. 3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.
Podona T; Guardiola-Lemaître B; Caignard DH; Adam G; Pfeiffer B; Renard P; Guillaumet G
J Med Chem; 1994 Jun; 37(12):1779-93. PubMed ID: 7912735
[TBL] [Abstract][Full Text] [Related]
2. 3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].
Comoy C; Marot C; Podona T; Baudin ML; Morin-Allory L; Guillaumet G; Pfeiffer B; Caignard DH; Renard P; Rettori MC; Adam G; Guardiola-Lemaitre B
J Med Chem; 1996 Oct; 39(21):4285-98. PubMed ID: 8863806
[TBL] [Abstract][Full Text] [Related]
3. 5-substituted 3,4-dihydro-3-amino-2H-1-benzopyran derivatives: synthesis and interaction with serotoninergic receptors.
Rezaie R; Joseph B; Bremner JB; Delagrange P; Kopp C; Misslin R; Pfeiffer B; Renard P; Guillaumet G
J Pharm Pharmacol; 2001 Jul; 53(7):959-68. PubMed ID: 11480547
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.
Hammarberg E; Nordvall G; Leideborg R; Nylöf M; Hanson S; Johansson L; Thorberg SO; Tolf BR; Jerning E; Svantesson GT; Mohell N; Ahlgren C; Westlind-Danielsson A; Csöregh I; Johansson R
J Med Chem; 2000 Jul; 43(15):2837-50. PubMed ID: 10956192
[TBL] [Abstract][Full Text] [Related]
5. Substituted 3-amino and/or 3-aminomethyl-3,4-dihydro-2H-1-benzopyrans: synthesis and biological activity.
Comoy C; Guérin V; Pfeiffer B; Rettori MC; Renard P; Guillaumet G
Bioorg Med Chem; 2000 Mar; 8(3):483-95. PubMed ID: 10732964
[TBL] [Abstract][Full Text] [Related]
6. [New serotonergic ligands with a benzopyran or dioxinopyridine structure: synthesis and activity].
Guillaumet G
J Pharm Belg; 1994; 49(3):216-20. PubMed ID: 7914534
[No Abstract] [Full Text] [Related]
7. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
[TBL] [Abstract][Full Text] [Related]
8. Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
Campiani G; Morelli E; Gemma S; Nacci V; Butini S; Hamon M; Novellino E; Greco G; Cagnotto A; Goegan M; Cervo L; Dalla Valle F; Fracasso C; Caccia S; Mennini T
J Med Chem; 1999 Oct; 42(21):4362-79. PubMed ID: 10543880
[TBL] [Abstract][Full Text] [Related]
9. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines.
Moltzen EK; Perregaard J; Meier E
J Med Chem; 1995 May; 38(11):2009-17. PubMed ID: 7783132
[TBL] [Abstract][Full Text] [Related]
10. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
[TBL] [Abstract][Full Text] [Related]
11. Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
Chumpradit S; Kung MP; Vessotskie J; Foulon C; Mu M; Kung HF
J Med Chem; 1994 Nov; 37(24):4245-50. PubMed ID: 7990123
[TBL] [Abstract][Full Text] [Related]
12. New benzocycloalkylpiperazines, potent and selective 5-HT1A receptor ligands.
el Ahmad Y; Laurent E; Maillet P; Talab A; Teste JF; Dokhan R; Tran G; Ollivier R
J Med Chem; 1997 Mar; 40(6):952-60. PubMed ID: 9083484
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of N,N'-bis-aminoalkyl-substituted derivatives of bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide with potential anxiolytic activity.
Turło J; Zawadowski T
Farmaco; 1996 Dec; 51(12):815-8. PubMed ID: 9050215
[TBL] [Abstract][Full Text] [Related]
15. (R)-1,2,3,4-tetrahydro[1]benzothieno[2,3-c]pyridines: novel optically active compounds with strong 5-HT1A receptor binding ability exhibiting anticonflict activity and lessening of memory impairment.
Kawakubo H; Takagi S; Yamaura Y; Katoh S; Ishimoto Y; Nagatani T; Mochizuki D; Kamata T; Sasaki Y
J Med Chem; 1993 Nov; 36(23):3526-32. PubMed ID: 7902439
[TBL] [Abstract][Full Text] [Related]
16. [[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives as high-affinity, selective 5-HT1A receptor ligands.
Modica M; Santagati M; Russo F; Parotti L; De Gioia L; Selvaggini C; Salmona M; Mennini T
J Med Chem; 1997 Feb; 40(4):574-85. PubMed ID: 9046348
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.
Johansson L; Sohn D; Thorberg SO; Jackson DM; Kelder D; Larsson LG; Rényi L; Ross SB; Wallsten C; Eriksson H; Hu PS; Jerning E; Mohell N; Westlind-Danielsson A
J Pharmacol Exp Ther; 1997 Oct; 283(1):216-25. PubMed ID: 9336327
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of N-(4-aryl-1-piperazinylbutyl)-substituted 7,8-benzo-1,3-diazaspiro[4,5]decane-2,4-dione derivatives with potential anxiolytic activity.
Kossakowski J; Zawadowski T; Turło J; Kleps J
Farmaco; 1998 Feb; 53(2):169-71. PubMed ID: 9604324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
